Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


AZ signs yet another cancer immunotherapy deal

AZ signs yet another cancer immunotherapy deal AZ has several research collaborations involving this drug, including one with Advaxis that was signed in July last year, as well as deals with Johnson &Johnson and Pharmacyclics to test various

Pharma deals during November 2014

Pharma deals during November 2014 As part of its defence strategy Pharmacyclics and its partner J&J continue to collaborate with players across the industry. ... Pharmacyclics will carry out phase I and phase IIa studies, but no financial terms were disclosed.

PD-1 inhibitors shine at ASH conference

PD-1 inhibitors shine at ASH conference AstraZeneca (AZ) is looking in that direction with its anti-PD-1 candidate MEDI4736, which is being tested alongside Johnson &Johnson (J&J) and Pharmacyclics' Imbruvica (ibrutinib) in haematological cancers including

Pharma deals during October 2014

Pharma deals during October 2014 A tri-partite arrangement between BMS, J&J and Pharmacyclics has been put in place again around Opdivo.

AZ advances immuno-oncology ambitions

AZ advances immuno-oncology ambitions Buys imaging company and signs PD-1 collaborations with Pharmacyclics and J&J. ... A two-part trial will be conducted by Pharmacyclics, while financial terms of the agreement have not been disclosed.

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected healthcare organisations to create powerful digital experiences. We help our...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...